ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers

Xu, Yi; Leng, Kaiming; Yao, Yue; Kang, Pengcheng; Liao, Guanqun; Han, Yi; Shi, Guangjun; Ji, Daolin; Huang, Peng; Zheng, Wangyang; Li, Zhenglong; Li, Jinglin; Huang, Lining; Yu, Liang; Zhou, Yongxu; Jiang, Xingming; Wang, Hao; Li, Chunlong; Su, Zhilei; Tai, Sheng; Zhong, Xiangyu; Wang, Zhidong; Cui, Yunfu*南方医科大学; 青岛大学; 哈尔滨医科大学
Hepatology2021-4DOI: 10.1002/hep.31493
98被引4阅读
引用收藏
分享

摘要

Background and Aims Circular RNAs (circRNAs) and extracellular vesicles (EVs) are involved in various malignancies. We aimed to clarify the functions and mechanisms of dysregulated circRNAs in the cells and EVs of cholangiocarcinoma (CCA). @@@ Approach and Results CircRNA microarray was used to identify circRNA expression profiles in CCA tissues and bile-derived EVs (BEVs). CCA-associated circRNA 1 (circ-CCAC1) expression was measured by quantitative real-time PCR. The clinical importance of circ-CCAC1 was analyzed by receiver operating characteristic curves, Fisher's exact test, Kaplan-Meier plots, and Cox regression model. The functions of circ-CCAC1 and exosomal circ-CCAC1 were explored in CCA cells and human umbilical vein endothelial cells (HUVECs), respectively. Different animal models were used to verify the in vitro results. RNA sequencing, bioinformatics, RNA immunoprecipitation, RNA pulldown, chromatin immunoprecipitation followed by sequencing, and luciferase reporter assays were used to determine the regulatory networks of circ-CCAC1 in CCA cells and HUVECs. Circ-CCAC1 levels were increased in cancerous bile-resident EVs and tissues. The diagnostic and prognostic values of circ-CCAC1 were identified in patients with CCA. For CCA cells, circ-CCAC1 increased cell progression by sponging miR-514a-5p to up-regulate Yin Yang 1 (YY1). Meanwhile, YY1 directly bound to the promoter of calcium modulating ligand to activate its transcription. Moreover, circ-CCAC1 from CCA-derived EVs was transferred to endothelial monolayer cells, disrupting endothelial barrier integrity and inducing angiogenesis. Mechanistically, circ-CCAC1 increased cell leakiness by sequestering enhancer of zeste homolog 2 in the cytoplasm, thus elevating SH3 domain-containing GRB2-like protein 2 expression to reduce the levels of intercellular junction proteins. In vivo studies further showed that increased circ-CCAC1 levels in circulating EVs and cells accelerated both CCA tumorigenesis and metastasis. @@@ Conclusions Circ-CCAC1 plays a vital role in CCA tumorigenesis and metastasis and may be an important biomarker/therapeutic target for CCA.

相关
加载中…
  • Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p/SFRP2 axis
    Zhang, Xinyu; Zhao, Yuqiao; Wang, Weina; Yu, Shaobo; Liu, Lang; Sun, Dongsheng*; Li, Wenzhi*; Jiang, Xingming*Pathology Research and Practice, 2022, 234: 153901.被引 6
  • Non-Coding RNA in Cholangiocarcinoma: An Update
    Li, Jiehan; Bao, Haolin; Huang, Ziyue; Liang, Zixin; Lin, Ning; Ni, Chunjie; Xu, Yi*Frontiers in Bioscience-Landmark, 2023, 28(8): 173.被引 3
  • Circular RNAs in pancreatic cancer progression
    Bao, Haolin; Li, Jiehan; Dong, Qingfu; Liang, Zixin; Yang, Chengru; Xu, Yi*Clinica Chimica Acta, 2024, 552: 117633.
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology
发表日期
2021-04
卷期
第 73 卷, 第 4 期
页码
1419-1435
DOI
10.1002/hep.31493
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE

作者

  • X

    Xu, Yi (第一作者)

    harbin med univ · 2

  • L

    Leng, Kaiming

    harbin med univ · qingdao municipal hosp · qingdao univ

查看全部 23 位作者收起作者
  • Y

    Yao, Yue

    harbin med univ · 2

  • K

    Kang, Pengcheng

    2 · harbin med univ

  • L

    Liao, Guanqun

    southern med univ

  • H

    Han, Yi

  • S

    Shi, Guangjun

    qingdao municipal hosp · qingdao univ

  • J

    Ji, Daolin

    harbin med univ · 2

  • H

    Huang, Peng

    harbin med univ · 2

  • Z

    Zheng, Wangyang

    harbin med univ · 2

  • L

    Li, Zhenglong

    harbin med univ · 2

  • L

    Li, Jinglin

    harbin med univ · 2

  • H

    Huang, Lining

    harbin med univ · 2

  • Y

    Yu, Liang

    2 · harbin med univ

  • Z

    Zhou, Yongxu

    2 · harbin med univ

  • J

    Jiang, Xingming

    2 · harbin med univ

  • W

    Wang, Hao

    2 · harbin med univ

  • L

    Li, Chunlong

    2 · harbin med univ

  • S

    Su, Zhilei

    2 · harbin med univ

  • T

    Tai, Sheng

    2 · harbin med univ

  • Z

    Zhong, Xiangyu

    2 · harbin med univ

  • W

    Wang, Zhidong

    2 · harbin med univ

  • C

    Cui, Yunfu (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417